Abstract:Gene therapy holds great potential for treating almost any disease by gene silencing, protein expression, or gene correction. To efficiently deliver the nucleic acid payload to its target tissue, the genetic material needs to be combined with a delivery platform. Lipid nanoparticles (LNPs) have proven to be excellent delivery vectors for gene therapy and are increasingly entering into routine clinical practice. Over the past two decades, the optimization of LNP formulations for nucleic acid delivery has led to a well-established body of knowledge culminating in the first-ever RNA interference therapeutic using LNP technology, i.e. Onpattro®, and many more in clinical development to deliver various nucleic acid payloads. Screening a lipid library in vivo for optimal gene silencing potency in hepatocytes resulted in the identification of the Onpattro® formulation. Subsequent studies discovered that the key to Onpattro®'s liver tropism is its ability to form a specific "biomolecular corona". In fact, apolipoprotein E (ApoE), among other proteins, adsorbed to the LNP surface enables specific hepatocyte targeting. This proof-of-principle example demonstrates the use of the biomolecular corona for targeting specific receptors and cells, thereby opening up the road to rationally designing LNPs. To date, however, only a few studies have explored in detail the corona of LNPs and how to efficiently modulate the corona remains poorly understood. In this review, we summarize recent discoveries about the biomolecular corona, expanding the knowledge gained with other nanoparticles to LNPs for nucleic acid delivery. In particular, we address how particle stability, biodistribution, and targeting of LNPs can be influenced by the biological environment. Onpattro® is used as a case study to describe both the successful development of an LNP formulation for gene therapy and the key influence of the biological environment. Moreover, we outline the techniques available to isolate and analyze the corona of LNPs, and we highlight their advantages and drawbacks. Finally, we discuss possible implications of the biomolecular corona for LNP delivery and we examine the potential of exploiting the corona as a targeting strategy beyond the liver to develop next-generation gene therapies.

Nano–Bio Interactions: Exploring the Biological Behavior and the Fate of Lipid-Based Gene Delivery Systems

Lipid Nanoparticles: A Novel Gene Delivery Technique for Clinical Application

Lipid Nanoparticles for Nucleic Acid Delivery Beyond the Liver

Recent advances in lipid nanoparticles for delivery of nucleic acid, mRNA, and gene editing-based therapeutics

The Biomolecular Corona of Lipid Nanoparticles for Gene Therapy.

Modification of Lipid-Based Nanoparticles: An Efficient Delivery System for Nucleic Acid-Based Immunotherapy

Optimized Lipid Nanoparticles (lnps) for Organ-Selective Nucleic Acids Delivery in Vivo

Surface modification of lipid nanoparticles for gene therapy

Lipid Nanoparticles for Nucleic Acid Delivery to Endothelial Cells

Looking Back, Moving Forward: Lipid Nanoparticles as a Promising Frontier in Gene Delivery

Lipid Nanoparticle (LNP) Chemistry Can Endow Unique in Vivo RNA Delivery Fates Within the Liver That Alter Therapeutic Outcomes in a Cancer Model

The Future of Tissue-Targeted Lipid Nanoparticle-Mediated Nucleic Acid Delivery

Enhancing RNA-lipid nanoparticle delivery: Organ- and cell-specificity and barcoding strategies

Physiological Barriers and Strategies of Lipid‐based Nanoparticles for Nucleic Acid Drug Delivery

Microfluidic fabrication of lipid nanoparticles for the delivery of nucleic acids

Advancements in Lipid Nanoparticle Technologies for Precision Targeting in Therapeutic Delivery

Review of structural design guiding the development of lipid nanoparticles for nucleic acid delivery

Lipid Nanoparticles Optimized for Targeting and Release of Nucleic Acid

Passive, active and endogenous organ-targeted lipid and polymer nanoparticles for delivery of genetic drugs

Tuning Lipid Nanoparticles for RNA Delivery to Extrahepatic Organs

Development of Lipid Nanoparticles for the Delivery of Macromolecules Based on the Molecular Design of pH-Sensitive Cationic Lipids